Clinical Trials Browser

Phase 2/3 × Unknown × Lapatinib × Clear all

NCT03500380 2024-02-20

A Study of RC48-ADC Administered Intravenously to Patients With HER2-Positive Metastatic Breast Cancer With or Without Liver Metastases

Phase 2/3 Unknown

Breast Diseases, Breast Neoplasms

NCT03085368 2017-07-28

A Randomized Controlled Trial of HER-2 Positive Breast Cancer Patients Treated With Lapatinib vs Herceptin

Phase 2/3 Unknown

Breast Neoplasms

NCT00450203 2016-12-01

ST03

Phase 2/3 Unknown

Gastrointestinal

Oesophagogastric Cancer